Neurocognitive dysfunction in adolescents with recent onset major depressive disorder: a cross-sectional comparative study.
Saved in:
| Title: | Neurocognitive dysfunction in adolescents with recent onset major depressive disorder: a cross-sectional comparative study. |
|---|---|
| Authors: | Bienek, Olga, Allott, Kelly, Antonucci, Linda, Bertolino, Alessandro, Bonivento, Carolina, Borgwardt, Stephan, Brambilla, Paolo, Chisholm, Katharine, Dannlowski, Udo, Lichtenstein, Theresa K., Kambeitz, Joseph, Kambeitz-Ilankovic, Lana, Koutsouleris, Nikolaos, Lencer, Rebekka, Griffiths, Siân Lowri, Maggioni, Eleonora, Meisenzahl, Eva, Pantelis, Christos, Rosen, Marlene, Ruhrmann, Stephan |
| Source: | European Child & Adolescent Psychiatry. Jun2025, Vol. 34 Issue 6, p1873-1882. 10p. |
| Subjects: | Cognition disorders diagnosis, Cross-sectional method, Adolescent psychiatry, Disease duration, Descriptive statistics, Age factors in disease, Comparative studies, Factor analysis, Psychological tests, Mental depression, Adolescence, Adults |
| Abstract: | The aim of this study was to examine the neurocognitive deficits associated with the first episode of major depressive disorder (recent onset depression, ROD) in adolescents as compared to adult patients. Cross-sectional neurocognitive data from the baseline assessments of the PRONIA study with N = 650 (55.31% females) were analyzed. Based on a principal component analysis of eleven neurocognitive tests, we constructed an overall neurocognitive performance (NP) score. We examined mean score differences in NP between the groups of healthy controls (HC) and ROD and between adolescents (15–21 years) and adults (22–40 years) within a GLM approach. This accounts for unbalanced data with focus on interaction effects while controlling for effects of medication and educational years. Our results show lower NP for the ROD as compared to the HC group (d = − 0.29, p =.046) and lower NP for the adolescent group as compared to the adult group (d = − 0.29; p <.039). There was no interaction between these two group effects (F = 1.11; p =.29). Our findings suggest that the detrimental effect of ROD on neurocognitive functioning is comparable in adolescent and adult patients, since lower scores in adolescent patients are explained by effects of age and education. Neurocognitive impairment is an under addressed issue in clinical treatment guidelines for adolescent MDD. We suggest efficient monitoring in clinical practice by using an aggregate of the Digit Symbol Substitution Test and the Trail Making Test B, which highly correlated with the overall score of NP (r = 0.82). [ABSTRACT FROM AUTHOR] |
| Copyright of European Child & Adolescent Psychiatry is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | The aim of this study was to examine the neurocognitive deficits associated with the first episode of major depressive disorder (recent onset depression, ROD) in adolescents as compared to adult patients. Cross-sectional neurocognitive data from the baseline assessments of the PRONIA study with N = 650 (55.31% females) were analyzed. Based on a principal component analysis of eleven neurocognitive tests, we constructed an overall neurocognitive performance (NP) score. We examined mean score differences in NP between the groups of healthy controls (HC) and ROD and between adolescents (15–21 years) and adults (22–40 years) within a GLM approach. This accounts for unbalanced data with focus on interaction effects while controlling for effects of medication and educational years. Our results show lower NP for the ROD as compared to the HC group (d = − 0.29, p =.046) and lower NP for the adolescent group as compared to the adult group (d = − 0.29; p <.039). There was no interaction between these two group effects (F = 1.11; p =.29). Our findings suggest that the detrimental effect of ROD on neurocognitive functioning is comparable in adolescent and adult patients, since lower scores in adolescent patients are explained by effects of age and education. Neurocognitive impairment is an under addressed issue in clinical treatment guidelines for adolescent MDD. We suggest efficient monitoring in clinical practice by using an aggregate of the Digit Symbol Substitution Test and the Trail Making Test B, which highly correlated with the overall score of NP (r = 0.82). [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 10188827 |
| DOI: | 10.1007/s00787-024-02599-0 |
